Hantavirus: Structure, Mechanism of Transmission of Disease, Development of Drugs and Vaccines, and Prevention in Indonesia

Nur Sabiq Assadah, I Sendow, NLP I Dharmayanti


Hantavirus is a zoonosis transmitted by rodents and have been spread in various countries. Hantavirus causes Hantavirus Pulmonary Syndrome (HPS) and Haemorrhagic Fever with Renal Syndrome (HFRS) in humans is still receiving worldwide attention due to the high case fatality rate. Epidemiological studies have shown that Hantavirus is widespread globally, including in Indonesia. Indonesia is an archipelago and has a tropical climate, and is crossed by the equator so that it has an enormous diversity of animals, including those that become reservoirs of Hantavirus and other vulnerable animals. The high risk of developing Hantavirus in Indonesia does not rule out the possibility of a Hantavirus outbreak if no preventive action is taken. Until now there is no effective and safe vaccine or treatment for Hantavirus. Various development efforts continue to be made to obtain an appropriate and safe vaccine to prevent and stop the spread of Hantavirus. This paper discusses Hantavirus, including its structure and mechanism of transmission, the current situation of Hantavirus in Indonesia and the efforts that can be made to prevent Hantavirus, including the development of vaccines and their drugs.


Virus structure; Hantavirus; prevention; transmission; vaccines

Full Text:



Alonso DO, Sautu UP, Bellomo CM, Prieto K, Iglesias A, Coelho R, Periolo N, Domenech I, Talmon G, Hansen R, Palacios G, Martinez VP. 2020. Person-to-person transmission of Andes Virus in Hantavirus. Pulmonary. 26:5–8.

Chandy S, Mathai D. 2020. Globally emerging Hantaviruses: An overview. Indian J Med Microbiol. 35:165-175.

Christova I, Pishmisheva M, Trifonova I, Vatev N, Stoycheva M, Tiholova M, Igova D, Baev M, Karagyaurova, Prokopova U. 2017. Clinical aspects of Hantavirus infections in Bulgaria. Wien Klin Wochenschr. 129:572-578.

Custer DM, Thompson E, Schmaljohn CS, et al. 2003 Active and passive vaccination against hantavirus pulmonary syndrome with Andes virus M genome segment-based DNA vaccine. J Virol. 77:9894-9905

Forbes KM, Sironen T, Plyusnin A. 2018. Hantavirus maintenance and transmission in reservoir host populations. Current Opinion Virol. 28:1–6.

Hart CA. Bennett M. 1999. Hantavirus infections: epidemiology and pathogenesis. Microbes Infect. 1:1229-1237.

Hjelle B. 2002. Vaccines against hantaviruses. Expert Rev Vaccines. 1:373-384.

Hooper JW, Custer DM, Thompson E, Schmaljohn CS. 2001. DNA vaccination with the Hantaan virus M gene protects hamsters against three of four HFRS Hantaviruses and elicits a high-titer neutralizing antibody response in Rhesus monkeys. J Virol. 75:8469-8477.

Ibrahim IN, Shimizu K, Yoshimatsu K, Yunianto A, Salwati E, Yasuda SP, Koma T, Endo R, Arikawa J. 2013. Epidemiology of Hantavirus infection in Thousand Islands Regency of Jakarta, Indonesia. J Vet Med Sci. 75:1003-1008.

Jiang H, Zheng X, Wang L, Du H, Wang P, Bai X. 2017. Hantavirus infection: a global zoonotic challenge. Virologica Sinica. 32:32-43.

Jonsson CB, Figueiredo LTM, Vapalahti O. 2010. A global perspective on Hantavirus ecology, epidemiology, and disease. Clin Microbiol Rev. 23: 412–441.

Jung J, Ko SJ, Oh HS, Moon SM, Song JW, Huh K. 2017. Protective effectiveness of inactivated Hantavirus vaccine against Hemorrhagic Fever with Renal Syndrome. JID. 217:1417-1420.

Kaplan M, Manore CA, Bagamian KH. 2016. Agent-based Hantavirus transmission model incorporating host behavior and viral shedding heterogeneities derived from field transmission experiments. Lett Biomaths. 3:209-228.

Klempa B. 2009. Hantaviruses and climate change. Clin Microbiol Infect. 15:518-523.

Kofman A, Eggers P, Kjemtrup A. 2018. Contact tracing investigation after first case of Andes Virus in the United States-Delaware, February 2018. MMorbid Mortal Wkly Rep. 67:1162–1163.

Kruger DH, Schonrich G, Klempa B. 2011. Human pathogeniv Hantaviruses and prefention of infection. Human Vaccines. 7:685-693.

Lie KC, Aziz MH, Kosasih H, Neal A, Halim CL, Wulan WN, Karyana M, Hadi U. 2018. Case report: two confirmed cases of human Seoul virus infections in Indonesia. BMC Infect Dis. 18:1-6.

Lukman N, Kosasih H, Ibrahim IN, Pradana AA, Neal A, Karyana M. 2019. A review of Hantavirus research in Indonesia: Prevalence in humans and rodents, and the discovery of Serang virus. Viruses. 11:698. doi: 10.3390/v11080698.

MacNeil A, Nichol ST, Spiropoulou CF. 2011. Hantavirus Pulmonary Syndrome. Virus Res. 162:138-147.

Madrieres S, Castel G, Murri S, Vulin J, Marianneau P, Charbonnel N. 2019. The needs for developing experiments on reservoirs in Hantavirus research: Accomplishments, challenges and promises for the future. Viruses. 11:664. doi: 10.3390/v11070664.

Maes P, Clement J, Rast MC. 2009. Recent approaches in Hantavirus vaccine development. Expert Rev Vacc. 8:67-76.

Moreli ML, Marques-Silva AC, Pimentel VA, da Costa VG. 2014. Effectiveness of the ribavirin in treatment of Hantavirus infections in the Americas and Eurasia: a meta-analysis. Virus Dis. 25:385-389.

Mulyono A, Ristiyanto, Handayani FD, Susanti L, Raharjo J. 2017a. Catatan baru reservoir Hantavirus dari Provinsi Jawa Tengah, Indonesia. Vektora. 9:51-58.

Mulyono A, Ristiyanto, Putro DBW. 2017b. Infeksi ganda Leptospira dan Hantavirus pada Rattus norvegicus di Maumere Flores, Nusa Tenggara Timur. BALABA. 13:93-104.

Muyangwa M, Martynova EV, Khaiboullina SF, Marzunov SP, Rizvanov AA. 2015. Hantaviral proteins: Structure, functions, and role in Hantavirus infection. Front Microbiol. 6:1-10.

Park K, Kim CS, Moon KT. 2004. Protective effectiveness of Hantavirus vaccine. Emerg Infect Dis. 10:2218-20.

Perwitasari D, Ibrahim IN, Yasmon A. 2014. Gene S characterization of Hantavirus species Seoul virus isolated from Rattus norvegicus on an Indonesian island. Health Sci Indones. 5:1-6.

Reuter M, Kruger DH. 2018. The nucleocapsid protein of Hantaviruses: much more than a genome-wrapping protein. Virus Genes. 54:5-16.

Santoso, Suryaningtyas NH, Salim M. 2018. Distribusi jenis tikus yang terkonfirmasi sebagai reservoir Hantavirus di Provinsi Sumatera Selatan. Buletin Penelitian Kesehatan. 46:191-198.

Schmaljohn CS. 2012. Vaccines for Hantaviruses: Progress and issues. Expert Rev Vacc. 11:511-513. doi: 10.1586/erv.12.15

Schonrich G, Rang A, Lutteke N, Raftery MJ, Charbonnel N, Ulrich RG. 2008. Hantavirus‐induced immunity in rodent reservoirs and humans. Immunol Rev. 225:163-189. doi: 10.1111/j.1600-065x.2008.00694.x

Schountz T. 2013. Diseases caused by Hantaviruses. Viral Hemorrhagic Fevers. 33:323–343. doi: 10.1016/B978-1-4160-4390-4.00192-2.

Sendow I, Dharmayanti NLPI, Saepulloh M, Adjid RMA. 2016. Infeksi Hantavirus: Penyakit zoonosis yang perlu diantisipasi keberadaannya di Indonesia. Wartazoa. 26:017-026 doi: 10.14334/wartazoa.v26i1. 1270.

Vapalahti O, Mustonen J, Lundkvist A, Henttonen H, Plyusnin A, Vaheri A. 2003. Hantavirus infections in Europe. Lancet Infect Dis. 3:653-61.

Wang X, Shen W, Qin Y, Ying L, Li H, Lu J, Lu J, Zhang N. 2020. A case-control study on the risk factors for hemorrhagic fever with renal syndrome. BMC Infect Dis. 20:1–7.

Witkowski PT, Perley CC, Brocato RL, Hooper JW, Jurgensen C, Schulzke JD, Kruger DH, Bucker R. 2017. Gastrointestinal tract as entry route for Hantavirus infection. Front Microbiol. 8:1-9.

Yi Y, Park H, Jung J. 2018. Effectiveness of inactivated Hantavirus vaccine on the disease severity of hemorrhagic fever with renal syndrome. Kidney Res Clin Pract. 37:366–372. doi: 10.23876/j.krcp.18.0044.

Yoshimatsu K, Arikawa J. 2014. Serological diagnosis with recombinant N antigen for Hantavirus infection. Virus Res. 187:77-83. doi: 10.1016/j.virusres.2013.12.040.

Zhang YZ, Zou Y, Fu ZF, Plyusnin A. 2010. Hantavirus infections in humans and animals, China. Emerg Infect Dis. 16:1195-1203.

Zupanc TA, Saksida A, Korva M. 2019. Hantavirus infections. Clin Microbiol Infect. 21:e6-e16.


  • There are currently no refbacks.

Copyright (c)  2020 WARTAZOA. Indonesian Bulletin of Animal and Veterinary Sciences

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.